NuvOx Pharma will target a USD 15m Series A raise in 2014 for its glioblastoma multiforme (GBM) candidate, NVX108,
according to Chief Business Officer David Wilson. (Source: BioPharm Insight) Continue reading
Ulthera® System Receives Third FDA Clearance
Non-Invasive Ultherapy® Ultrasound Procedure Recognized for Imaging Capabilities
Gore and AAAneurysm Outreach Partner to Increase Early Detection of Abdominal Aortic Aneurysm (AAA)
New Campaign Will Employ Awareness, Community Outreach, and Patient Screening to Fight AAAContinue reading
UA Researchers Find Culprit Behind Skeletal Muscle Disease
Mutations in a protein that is vital for proper muscle function can cause skeletal muscle disease, a new study finds. Understanding the cause of such myopathies may enable researchers to develop treatments.Continue reading
Groundbreaking Research Explores Link Between Traumatic Brain Injury and Sleep
There is a lack of experimental evidence to support the common belief that sleep should not be allowed following a brain injury.Continue reading
UA Study Shows Aggressive Management of Gunshot Wounds to Brain Significantly Increases Survival
Gunshot wounds to the brain are the most lethal of firearm injuries, with survival rates of 10 percent to 15 percent.Continue reading
Yulex Corporation Opens Guayule Seed & Genetics Center
— Yulex Corporation, an agricultural biomaterials company, today announced the opening of a Seed & Genetics Center focused on plant breeding, molecular genetics and development of agronomic best practices to support the global cultivation of sustainable guayule plantations for medical, consumer, industrial and bioenergy applications.Continue reading
Medtronic CoreValve® System Obtains Early FDA Approval on Exceptional Clinical Performance
Self-Expanding Aortic Valve Serves Broad Spectrum of Potential Transcatheter Aortic Valve Replacement (TAVR) Patients Who Are Unable to Undergo SurgeryContinue reading
Telestroke is cost-saving for society Mayo Clinic researchers show
PHOENIX — Jan. 16, 2014 — Researchers have found that using telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for society. The research was recently published in the American Journal of Managed Care.Continue reading
Insys Announces Details of Product Development Pipeline
PHOENIX, AZ–(Marketwired – Jan 13, 2014) – Insys Therapeutics, Inc. (NASDAQ: INSY) today unveiled details of its portfolio pipeline, focused on innovative supportive care and therapy products. The Company intends to file one New Drug Application (NDA) and at least three Investigational New Drug (IND) applications with the Food and Drug Administration (FDA) in 2014.
Continue reading